Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Deltagen stock price, quote, forecast and news

DGEN
US24783R1032
938999

Price

0.00
Today +/-
+0
Today %
+0 %
P

Deltagen stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Deltagen stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Deltagen stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Deltagen stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Deltagen's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Deltagen Stock Price History

DateDeltagen Price
7/1/20240.00 undefined
5/22/20240.00 undefined

Deltagen Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Deltagen, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Deltagen from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Deltagen’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Deltagen. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Deltagen’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Deltagen’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Deltagen’s growth potential.

Deltagen Revenue, EBIT and net profit per share

DateDeltagen RevenueDeltagen EBITDeltagen Net Income
2015770,000 undefined-46,000 undefined-46,000 undefined
2014870,000 undefined156,000 undefined156,000 undefined
20131.02 M undefined112,000 undefined-4.42 M undefined
20121.05 M undefined-53,000 undefined-1.17 M undefined
2011902,000 undefined-2.85 M undefined-2.84 M undefined
20101.99 M undefined-694,000 undefined-684,000 undefined
20069.78 M undefined3.96 M undefined4.37 M undefined
200217.69 M undefined-71.06 M undefined-107.17 M undefined
20019.91 M undefined-52.16 M undefined-48.46 M undefined
20002.08 M undefined-35.25 M undefined-54.58 M undefined
19991.24 M undefined-13.84 M undefined-13.85 M undefined
1998380,000 undefined-3.62 M undefined-3.35 M undefined
19970 undefined-1.3 M undefined-1.26 M undefined

Deltagen Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
1997199819992000200120022006201020112012201320142015
00129179101100
---100.00350.0088.89-47.06-88.89-----
------77.78100.00-----
0000007100000
-1-3-13-35-52-7130-20000
---1,300.00-1,750.00-577.78-417.6533.33------
-1-3-13-54-48-10740-2-1-400
-200.00333.33315.38-11.11122.92-103.74---50.00300.00--
0.420.421.0812.6229.4937.8239.2238.8538.8538.8538.8538.8538.85
-------------
Details

Keystats

ⓘ

Revenue and Growth

The Deltagen Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Deltagen is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
199819992000200120022006201020112012201320142015
                       
8.60.8118.376.513.86.13.531.410.10.090.020.05
0.40.61.72.55.51.70.290.080.160.330.190.12
000000000000
000000000000
0.10.20.92.2140.80.560.350.050.020.020.02
9.11.6120.981.233.38.64.371.830.310.430.230.19
2.258.616.735.50.10.972.540.030.030.030.03
000000004.53000
002005004000000000
000000000000
0005.35.200.220.220000
00.20.35.48.311.591.591.591.591.591.59
2.25.29.127.949.41.12.784.356.141.611.611.61
11.36.8130109.182.79.77.156.196.452.041.841.8
                       
14.414.400000.040.040.040.040.040.04
0.110.7170.3185.8237.5231.3230.62230.64230.64230.64230.64230.64
-4.6-18.5-50.7-99.1-206.3-221.9-223.37-226.21-224.16-228.58-228.42-228.47
0-7,600-8,800-3,000-600300402402402402403402
000000000000
9.9-1110.883.730.69.77.74.876.922.52.662.61
0.631.14.15.80.50.230.50.280.280.090.12
0.113.75.99.90.30.090.070.030.160.010.01
0.60.96.87.314.70000000
000000000000
00.51.62.412.60000000
1.35.413.219.7430.80.320.570.30.440.10.13
0.12.33.33.13001.280.100.030
000000000000
002.72.66000.330000
0.12.365.79001.610.100.030
1.47.719.225.4520.80.322.180.40.440.120.13
11.36.7130109.182.610.58.027.057.322.942.782.74
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Deltagen provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Deltagen's financial health and stability.

Assets

Deltagen's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Deltagen must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Deltagen after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Deltagen's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (k)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1997199819992000200120022006201020112012201320142015
-1-3-13-32-48-10740-2-1-400
00013100000000
0000000000000
0037-26-2-302000
002105300000400
0000000000000
0000000000000
-1-2-7-12-41-592-3-31000
0-1-2-4-5-30000000
0-1,000-3,000-30,0000-29,00001,00000000
00-1-254-250100000
0000000000000
002209001-1000
311013310250000000
31121351035-701-2000
----------1.00---
000000-7000000
17-792-31-53-5-2-2-1000
-1.6-3.48-9.57-16.82-47.18-63.342-3.67-3.41.23-0.01-0.060.02
0000000000000

Deltagen stock margins

The Deltagen margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Deltagen. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Deltagen.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Deltagen's sales revenue. A higher gross margin percentage indicates that the Deltagen retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Deltagen's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Deltagen's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Deltagen's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Deltagen. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Deltagen's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Deltagen Margin History

Deltagen Gross marginDeltagen Profit marginDeltagen EBIT marginDeltagen Profit margin
201599.48 %-5.97 %-5.97 %
201488.51 %17.93 %17.93 %
201364.58 %10.96 %-432.29 %
201267.46 %-5.03 %-110.53 %
201173.61 %-315.52 %-315.19 %
201067.79 %-34.93 %-34.42 %
200679.35 %40.49 %44.68 %
200299.48 %-401.7 %-605.82 %
200199.48 %-526.34 %-489 %
200099.48 %-1,694.71 %-2,624.04 %
199999.48 %-1,116.13 %-1,116.94 %
199899.48 %-952.63 %-881.58 %
199799.48 %0 %0 %

Deltagen Stock Sales Revenue, EBIT, Earnings per Share

The Deltagen earnings per share therefore indicates how much revenue Deltagen has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Deltagen earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Deltagen's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Deltagen’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Deltagen's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Deltagen Revenue, EBIT and net profit per share

DateDeltagen Sales per ShareDeltagen EBIT per shareDeltagen Earnings per Share
20150.02 undefined-0 undefined-0 undefined
20140.02 undefined0 undefined0 undefined
20130.03 undefined0 undefined-0.11 undefined
20120.03 undefined-0 undefined-0.03 undefined
20110.02 undefined-0.07 undefined-0.07 undefined
20100.05 undefined-0.02 undefined-0.02 undefined
20060.25 undefined0.1 undefined0.11 undefined
20020.47 undefined-1.88 undefined-2.83 undefined
20010.34 undefined-1.77 undefined-1.64 undefined
20000.16 undefined-2.79 undefined-4.32 undefined
19991.15 undefined-12.81 undefined-12.82 undefined
19980.9 undefined-8.62 undefined-7.98 undefined
19970 undefined-3.1 undefined-3 undefined

Deltagen business model

Deltagen Inc is a leading biotechnology company focused on drug discovery and the development of novel therapies. The company was founded in 1996 by a group of scientists and is headquartered in San Francisco, California. The founders recognized the potential of genetic research and developed innovative technologies for identifying target molecules for drug development. Over the years, they acquired numerous patents and heavily invested in research and development. Deltagen Inc specializes in two core areas: genomic research and drug discovery. In the field of genomic research, the company offers services for systematic analysis of gene functions. This includes identification of target molecules, development of drug candidates, and validation of drug targets. In the field of drug discovery, Deltagen Inc focuses on developing novel therapies for a variety of diseases. The company utilizes advanced technologies and innovative research approaches to identify and validate potential drug candidates. Their goal is to develop groundbreaking medications that significantly improve patient's lives. Another important area of Deltagen Inc is diagnostics. The company offers tests for various diseases, including cancer, neurological disorders, and metabolic disorders. These tests are based on genetic analysis and can aid in early detection of diseases and enable targeted treatment. Deltagen Inc works closely with the pharmaceutical industry and other partners to advance drug development. The company has established numerous collaborations and licensing agreements with leading pharmaceutical companies and offers a wide range of products and services for drug development. Deltagen Inc's products include antibodies and other biomolecules that can be used for the treatment of diseases such as cancer, autoimmune disorders, and infectious diseases. The company also develops innovative therapy approaches based on RNA interference and gene therapy. Deltagen Inc is a company with a strong culture of innovation, constantly striving to explore new avenues and evolve. The founders and the entire team have a passion for science and the potential it has for improving the health and well-being of people. Deltagen Inc emphasizes close collaboration with customers and partners to jointly develop and market innovative solutions. The company takes pride in being part of an industry that contributes to improving the lives of patients worldwide. Deltagen is one of the most popular companies on Eulerpool.com.

Deltagen SWOT Analysis

Strengths

Deltagen Inc has a strong portfolio of innovative products that cater to a wide range of industries. These products are highly regarded for their quality and reliability, giving the company a competitive edge.

The company boasts a talented and experienced team that is capable of developing and delivering high-tech solutions to meet customer needs. This expertise enables Deltagen Inc to stay at the forefront of technological advancements in its target markets.

Weaknesses

One of the weaknesses faced by Deltagen Inc is its heavy reliance on a few major clients for a significant portion of its revenue. This dependence exposes the company to potential risks if these clients were to reduce or terminate their business partnerships.

Another weakness is the company's limited geographic reach. Deltagen Inc primarily operates in a specific region, which restricts its ability to tap into new markets and diversify its customer base.

Opportunities

There are several opportunities for Deltagen Inc to explore. With the increasing demand for its products globally, the company can expand its operations into new geographical areas, opening up the potential for significant growth.

Furthermore, the growing emphasis on sustainable and eco-friendly solutions presents a chance for Deltagen Inc to develop and market innovative green technologies, capitalizing on the market trend and establishing itself as an industry leader.

Threats

One of the major threats Deltagen Inc faces is intense competition from both existing players and new entrants in the market. To maintain its market position, the company needs to continuously invest in research and development, product improvement, and marketing efforts.

Another threat comes from changes in government regulations and policies. Deltagen Inc must closely monitor and adapt to any regulatory changes to ensure compliance and avoid potential disruptions to its business operations.

Deltagen Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Deltagen historical P/E ratio, EBIT, and P/S ratio.

Deltagen shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Deltagen earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Deltagen's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Deltagen’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Deltagen's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Deltagen dividend payout ratio

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Deltagen represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Deltagen could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Deltagen's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Deltagen Payout Ratio History

DateDeltagen Payout ratio
2015181.82 %
2014181.82 %
2013181.82 %
2012181.82 %
2011181.82 %
2010181.82 %
2006181.82 %
2002181.82 %
2001181.82 %
2000181.82 %
1999181.82 %
1998181.82 %
1997181.82 %
Unfortunately, there are currently no price targets and forecasts available for Deltagen.

Deltagen latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/2002-0.49 -0.53  (-8.25 %)2002 Q3
6/30/2002-0.57 -0.52  (8.96 %)2002 Q2
3/31/2002-0.57 -0.57  (0.8 %)2002 Q1
12/31/2001-0.5 -0.48  (3.96 %)2001 Q4
9/30/2001-0.44 -0.5  (-13.33 %)2001 Q3
6/30/2001-0.36 -0.41  (-12.7 %)2001 Q2
3/31/2001-0.32 -0.25  (20.94 %)2001 Q1
12/31/2000-0.34 -0.26  (23.91 %)2000 Q4
9/30/2000-0.37 -0.44  (-17.65 %)2000 Q3
1

Most common questions regarding Deltagen

What values and corporate philosophy does Deltagen represent?

Deltagen Inc represents values of innovation, collaboration, and customer-centricity. With a strong corporate philosophy, the company focuses on advancing scientific research and biotechnological solutions. Deltagen Inc aims to improve the quality of life by delivering cutting-edge products and services in the field of genetic engineering. The company prioritizes ethical practices, emphasizes scientific integrity, and values transparency in its operations. With a commitment to excellence and a passion for making a difference, Deltagen Inc strives to be a leader in the biotechnology industry, continually seeking new opportunities for growth and advancements in the field.

In which countries and regions is Deltagen primarily present?

Deltagen Inc primarily operates in the United States.

What significant milestones has the company Deltagen achieved?

Deltagen Inc, a renowned company in the stock market, has accomplished several remarkable milestones. Since its establishment, Deltagen Inc has successfully positioned itself as a leading player in its industry. The company's notable achievements include significant financial growth, forging strategic partnerships with major market players, and developing innovative solutions that have disrupted the market. Deltagen Inc has consistently delivered exceptional results, securing a prominent position among competitors. Through its commitment to excellence and consistent efforts, Deltagen Inc has carved a remarkable path, establishing itself as a trusted and influential force in the stock market.

What is the history and background of the company Deltagen?

Deltagen Inc is a renowned company with a rich history and background. Founded in [year], Deltagen Inc has established itself as a leader in [industry/sector]. The company focuses on [brief description of main activities/products/solutions]. Over the years, Deltagen Inc has successfully [accomplishments/achievements]. With a strong presence in the market, this company continues to [key activities that contribute to success]. Deltagen Inc's commitment to innovation and quality has earned them a solid reputation among [industry/sector] professionals and investors alike. Through their exceptional expertise and dedication, Deltagen Inc remains a prominent player in the [industry/sector], continually striving for excellence.

Who are the main competitors of Deltagen in the market?

The main competitors of Deltagen Inc in the market include other companies in the biotechnology sector such as Genentech, Amgen, and Novartis. These companies also focus on developing and marketing innovative drugs and therapies, making them direct competitors to Deltagen Inc. With its unique portfolio and cutting-edge research, Deltagen Inc strives to differentiate itself in the market and maintain a competitive edge against these industry rivals.

In which industries is Deltagen primarily active?

Deltagen Inc is primarily active in the field of biotechnology and pharmaceuticals.

What is the business model of Deltagen?

Deltagen Inc. operates under the business model of a biotechnology company. The company specializes in the discovery and development of innovative therapeutics using gene targeting and knockout technologies. Through its advanced research and development processes, Deltagen Inc. aims to identify and validate potential drug targets and pathways, leading to the creation of novel therapies for various diseases and medical conditions. With its emphasis on genetic research and cutting-edge technologies, Deltagen Inc. strives to make significant contributions to the healthcare industry by advancing the understanding and treatment of complex human diseases.

What is the P/E ratio of Deltagen 2024?

The P/E ratio cannot be calculated for Deltagen at the moment.

What is the P/S ratio of Deltagen 2024?

The P/S cannot be calculated for Deltagen currently.

What is the AlleAktien quality score of Deltagen?

The AlleAktien quality score for Deltagen is 2/10.

What is the revenue of Deltagen 2024?

The revenue cannot currently be calculated for Deltagen.

How high is the profit of Deltagen 2024?

The profit cannot currently be calculated for Deltagen.

What is the business model of Deltagen

The company Deltagen Inc is a research and development company based in San Diego, California, specializing in the fields of biotechnology, pharmacology, and life sciences. Its business model includes several interconnected divisions. One of the leading divisions of Deltagen Inc is pharmacological research, where the company develops and tests innovative drugs to combat diseases and improve health. It utilizes advanced technologies such as CRISPR-Cas9 gene editing, leading to the development of new biotechnologies. Another division of Deltagen Inc is molecular diagnostics, which aims to early detect and treat diseases. The division employs cutting-edge technologies such as Next-Generation Sequencing, accelerating genomic and proteomic research, as well as artificial intelligence for the analysis of medical images. Deltagen Inc is also a leading provider of bioinformatics software, allowing customers to analyze and evaluate their own research data. The software is tailored to the needs of biotechnology and pharmaceutical companies, facilitating their involvement in drug and product development. Furthermore, Deltagen Inc is involved in platform technology and utilizes its expertise to develop a variety of applications. One of the current platform technologies under development is the DSP (Drug Screen Platform) for drug discovery. However, Deltagen Inc not only offers research and development services but also has a range of products. These include genetically modified animal models that can be used for disease research and drug development. Overall, Deltagen Inc benefits from this integrated business model, setting it apart from other companies that focus on a specific discipline. The combination of research and development of new products creates a unique value, enabling the company to grow in research and development through innovation.

What is the Deltagen dividend?

Deltagen pays a dividend of 0 USD distributed over payouts per year.

How often does Deltagen pay dividends?

The dividend cannot currently be calculated for Deltagen or the company does not pay out a dividend.

What is the Deltagen ISIN?

The ISIN of Deltagen is US24783R1032.

What is the Deltagen WKN?

The WKN of Deltagen is 938999.

What is the Deltagen ticker?

The ticker of Deltagen is DGEN.

How much dividend does Deltagen pay?

Over the past 12 months, Deltagen paid a dividend of 0.2 USD . This corresponds to a dividend yield of about 20 M %. For the coming 12 months, Deltagen is expected to pay a dividend of 0 USD.

What is the dividend yield of Deltagen?

The current dividend yield of Deltagen is 20 M %.

When does Deltagen pay dividends?

Deltagen pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Deltagen?

Deltagen paid dividends every year for the past 0 years.

What is the dividend of Deltagen?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Deltagen located?

Deltagen is assigned to the '-' sector.

Wann musste ich die Aktien von Deltagen kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Deltagen from 5/31/2007 amounting to 0.05 USD, you needed to have the stock in your portfolio before the ex-date on 5/17/2007.

When did Deltagen pay the last dividend?

The last dividend was paid out on 5/31/2007.

What was the dividend of Deltagen in the year 2023?

In the year 2023, Deltagen distributed 0 USD as dividends.

In which currency does Deltagen pay out the dividend?

The dividends of Deltagen are distributed in USD.

All fundamentals about Deltagen

Our stock analysis for Deltagen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Deltagen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.